Dallas, Texas Jan 28, 2026 (Issuewire.com) - Brillio, a global digital transformation company and The Enterprise AI Accelerator, announced today that it has been named a Leader in the HFS Horizons: Life Sciences Service Providers, 2025 report. The recognition reinforces Brillio’s growing influence in delivering AI-powered solutions that create measurable progress across healthcare and life sciences organizations.
The HFS Horizons report evaluated 41 service providers based on their innovation strength, go-to-market execution, and proven market impact. Brillio distinguished itself through its ability to deliver outcomes that extend beyond traditional performance benchmarks—supporting life sciences enterprises in achieving the Quadruple Aim of Care: improved health outcomes, reduced costs, enhanced patient experience, and greater equity in care delivery.
Mayank Madhur, Practice Leader for Healthcare and Life Sciences at HFS Research, noted that Brillio’s work stands out for its disciplined, results-focused use of AI and data. Rather than emphasizing industry buzzwords, Brillio has demonstrated measurable impact across critical healthcare priorities.
Driving Innovation Across Life Sciences
Brillio’s leadership is powered by its proprietary Agentic Data and App Management (ADAM) platform and its Personal Health Concierge solutions, enabling scalable, client-ready AI technologies.
The company continues to deliver tangible results through key innovations, including:
TrialOps Copilot, accelerating clinical trial execution
Safety Sentinel, improving pharmacovigilance efficiency
AI-driven supply chain optimization, reducing emissions while generating over $1.3 million in savings
Brillio’s life sciences strategy is further strengthened by a robust partner ecosystem that includes AWS, Microsoft, Google Cloud, Databricks, Salesforce, and Veeva Systems.
Avantika Sharma, Global Leader – Healthcare at Brillio, commented:
“This recognition from HFS validates our commitment to reimagining life sciences through AI and data-led innovation. By focusing on the outcomes that matter most—better health, lower costs, improved experiences, and equity—we are helping clients accelerate transformation at scale.”
Meeting the Industry’s Next Challenges
With rising R&D investments, shrinking margins, and increasing regulatory complexity, AI is rapidly reshaping clinical development, commercialization, and healthcare access. Brillio’s solutions are designed to help life sciences organizations respond to these pressures with greater speed, precision, sustainability, and patient-centered impact.
To learn more about Brillio’s recognition, visit : A Recognized Leader in HFS Horizon | Brillio
Media Contact
Brillio *****@brillio.com https://www.brillio.com/news-room/brillio-recognized-as-a-leader-in-hfs-horizons-life-sciences-service-providers-2025-report/
